z-logo
Premium
Comparison of chronic renal failure rats and modification of the preparation protocol as a hyperphosphataemia model
Author(s) -
TERAI KAZUHIRO,
MIZUKAMI KAZUHIKO,
OKADA MASAMICHI
Publication year - 2008
Publication title -
nephrology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.752
H-Index - 61
eISSN - 1440-1797
pISSN - 1320-5358
DOI - 10.1111/j.1440-1797.2007.00844.x
Subject(s) - dosing , medicine , hyperphosphatemia , endocrinology , chronic renal failure , kidney disease
SUMMARY: Background:  Several animal models with chronic renal failure have been established and used for demonstrating complications including hyperphosphataemia. Although long‐time feeding is required to cause hyperphosphataemia in animals, a few modifications have been reported to provide more useful models for research. Methods:  Three separate experiments were carried out in the present study. First, characteristics of commonly used subnephrectomized (5/6Nx) rats and rats fed an adenine diet (0.75% adenine in normal diet) were compared as hyperphosphataemia models. Next, using adenine‐diet rats, the inhibitory effect of sevelamer hydrochloride (Sev) on serum phosphorus elevation was examined. Third, oral adenine dosing for induction of hyperphosphataemia and validation as a model using Sev were examined. Results:  Serum phosphorus in 5/6Nx rats became elevated in 8–17 weeks, but the levels and time points of elevation differed among animals. In adenine‐fed rats, the elevation was more clearly demonstrated with less diversity at 4 weeks. The data revealed a potential shorter model preparation period and the importance of controlling feeding amounts. Oral adenine dosing induced hyperphosphataemia by 12 days, and Sev treatment was inhibitory. After a maintenance period of over a month (no treatments), Sev‐treated rats showed hyperphosphataemia as did oral adenine‐dosed control rats. The serum phosphorus levels significantly decreased on further Sev treatment. Conclusion:  Oral dosing with adenine made the model preparation period definitely shorter, and its usefulness as a hyperphosphataemia model was revealed using Sev.

This content is not available in your region!

Continue researching here.

Having issues? You can contact us here